VOGLISTAR GM1 (Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg))

Voglistar GM1 Tablet ER is classified as an anti-diabetic medication that combines several active ingredients aimed at managing type 2 diabetes mellitus in adults. This medication contributes to the regulation of blood glucose levels for individuals diagnosed with this condition. For optimal efficacy, it is advised to consume Voglistar GM1 Tablet ER in conjunction with meals or shortly before eating. It is important to adhere to the prescribed schedule, taking the medication consistently at the same time each day. Medical professionals will determine the appropriate dosage tailored to individual needs, which may be adjusted periodically based on blood glucose monitoring. It is crucial to continue using this medication even if there are improvements in health or blood sugar readings, as discontinuation without medical advice can lead to elevated glucose levels, increasing the risk of severe complications such as kidney damage, visual impairments, nerve issues, and potential amputations. This medication is part of a broader treatment strategy that includes adherence to a nutritious diet, routine physical activity, and weight management as recommended by your healthcare provider. Lifestyle modifications play a significant role in effective diabetes management. Patients should also be aware of the symptoms indicating low blood sugar levels—such as sweating, dizziness, headache, and tremors—and should carry quick sources of glucose, like sugary snacks or fruit juices, for emergencies. Additionally, alcohol consumption is discouraged due to its potential to lower blood sugar levels further. This medication may also cause side effects, including alterations in taste, gastrointestinal disturbances, headache, edema, visual blurriness, bone fractures, and respiratory infections, as well as possible weight gain.